October 21, 2020
1 min read
Higher-dose vitamin D supplementation may be a “promising approach” to reducing the risk for type 2 diabetes among adults with prediabetes, according to researchers. This was the top story in endocrinology last week.
Another top story was about an investigational once-daily pill that reduced HbA1c among certain adults with type 1 diabetes.
Read these and more top stories in endocrinology below:
Higher-dose vitamin D ‘promising approach’ to prevent type 2 diabetes
Daily vitamin D supplementation to achieve blood levels of vitamin D higher than typically recommended for bone health may reduce risk for type 2 diabetes among adults with prediabetes, according to a new analysis of the D2d study. Read more.
Investigational once-daily pill reduces HbA1c in type 1 diabetes, without hypoglycemia
An investigational once-daily pill added to optimized insulin therapy was shown to reduce HbA1c among adults with type 1 diabetes during a 12-week trial when compared with placebo plus insulin, according to a presenter at the European Association for the Study of Diabetes meeting. Read more.
Make an IMPACT: Leverage physician, mom identities to fight ‘infodemic’ during COVID-19
Fighting medical misinformation is an urgent priority during the COVID-19 pandemic, and physician mothers are uniquely positioned to leverage dual identities to help the public and policymakers discern what is true, according to a speaker at the virtual Women in Medicine Summit. Read more.
Bariatric surgery increases life expectancy vs. usual obesity care
Life expectancy increased by 3 years for adults with obesity who had bariatric surgery compared with usual care; however, life expectancy was still shorter than that for the general population, according to researchers in Sweden. Read more.
Antibody response in COVID-19 similar in adults with and without diabetes
Antibodies in adults with diabetes hospitalized with COVID-19 in Italy had a similar positive response to the SARS-CoV-2 spike protein as those without diabetes, according to findings published in Diabetologia. Read more.